BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 12237774)

  • 41. Vav2 activates Rac1, Cdc42, and RhoA downstream from growth factor receptors but not beta1 integrins.
    Liu BP; Burridge K
    Mol Cell Biol; 2000 Oct; 20(19):7160-9. PubMed ID: 10982832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rho guanosine 5'-triphosphatases differentially regulate insulin-like growth factor I (IGF-I) receptor-dependent and -independent actions of IGF-II on human trophoblast migration.
    Shields SK; Nicola C; Chakraborty C
    Endocrinology; 2007 Oct; 148(10):4906-17. PubMed ID: 17640993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterotrimeric G protein betagamma subunits stimulate FLJ00018, a guanine nucleotide exchange factor for Rac1 and Cdc42.
    Ueda H; Nagae R; Kozawa M; Morishita R; Kimura S; Nagase T; Ohara O; Yoshida S; Asano T
    J Biol Chem; 2008 Jan; 283(4):1946-53. PubMed ID: 18045877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Involvement of Rho GTPases and their effectors in the secretory process of PC12 cells.
    Frantz C; Coppola T; Regazzi R
    Exp Cell Res; 2002 Feb; 273(2):119-26. PubMed ID: 11822867
    [TBL] [Abstract][Full Text] [Related]  

  • 45. G alpha 13 signals via p115RhoGEF cascades regulating JNK1 and primitive endoderm formation.
    Lee YN; Malbon CC; Wang HY
    J Biol Chem; 2004 Dec; 279(52):54896-904. PubMed ID: 15492006
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specificity of Rho insert-mediated activation of phospholipase D1.
    Walker SJ; Brown HA
    J Biol Chem; 2002 Jul; 277(29):26260-7. PubMed ID: 12011045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A current overview of RhoA, RhoB, and RhoC functions in vascular biology and pathology.
    Eckenstaler R; Hauke M; Benndorf RA
    Biochem Pharmacol; 2022 Dec; 206():115321. PubMed ID: 36306821
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
    Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
    J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction of protein kinase C isozymes with Rho GTPases.
    Slater SJ; Seiz JL; Stagliano BA; Stubbs CD
    Biochemistry; 2001 Apr; 40(14):4437-45. PubMed ID: 11284700
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium botulinum C3 ADP-ribosyltransferase.
    Aktories K; Mohr C; Koch G
    Curr Top Microbiol Immunol; 1992; 175():115-31. PubMed ID: 1628497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility.
    Wheeler AP; Ridley AJ
    Exp Cell Res; 2004 Nov; 301(1):43-9. PubMed ID: 15501444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.
    Simpson KJ; Dugan AS; Mercurio AM
    Cancer Res; 2004 Dec; 64(23):8694-701. PubMed ID: 15574779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vav2 is an activator of Cdc42, Rac1, and RhoA.
    Abe K; Rossman KL; Liu B; Ritola KD; Chiang D; Campbell SL; Burridge K; Der CJ
    J Biol Chem; 2000 Apr; 275(14):10141-9. PubMed ID: 10744696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rho GTPases in embryonic development.
    Duquette PM; Lamarche-Vane N
    Small GTPases; 2014; 5(2):8. PubMed ID: 25483305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG.
    Zalcman G; Closson V; Camonis J; Honoré N; Rousseau-Merck MF; Tavitian A; Olofsson B
    J Biol Chem; 1996 Nov; 271(48):30366-74. PubMed ID: 8939998
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How Vav proteins discriminate the GTPases Rac1 and RhoA from Cdc42.
    Movilla N; Dosil M; Zheng Y; Bustelo XR
    Oncogene; 2001 Dec; 20(56):8057-65. PubMed ID: 11781818
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rho protein inactivation induced apoptosis of cultured human endothelial cells.
    Hippenstiel S; Schmeck B; N'Guessan PD; Seybold J; Krüll M; Preissner K; Eichel-Streiber CV; Suttorp N
    Am J Physiol Lung Cell Mol Physiol; 2002 Oct; 283(4):L830-8. PubMed ID: 12225960
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutation status of genes encoding RhoA, Rac1, and Cdc42 GTPases in a panel of invasive human colorectal and breast tumors.
    Rihet S; Vielh P; Camonis J; Goud B; Chevillard S; de Gunzburg J
    J Cancer Res Clin Oncol; 2001 Dec; 127(12):733-8. PubMed ID: 11768613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guanine nucleotide-dependent ADP-ribosylation of soluble rho catalyzed by Clostridium botulinum C3 ADP-ribosyltransferase. Isolation and characterization of a newly recognized form of rhoA.
    Williamson KC; Smith LA; Moss J; Vaughan M
    J Biol Chem; 1990 Dec; 265(34):20807-12. PubMed ID: 2174426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.